PFGIA
MBRX icon

Patriot Financial Group Insurance Agency’s Moleculin Biotech MBRX Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1
Closed -$2K – 1766
2020
Q1 		$2K Hold
1
– – ﹤0.01% 1313
2019
Q4 		$2K Hold
1
– – ﹤0.01% 1131
2019
Q3 		$3K Hold
1
– – ﹤0.01% 1030
2019
Q2 		$3K Hold
1
– – ﹤0.01% 1048
2019
Q1 		$2K Hold
1
– – ﹤0.01% 1023
2018
Q4 		$3K Buy
+1
New +$2.87K ﹤0.01% 795

Other funds holding MBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Patriot Financial Group Insurance Agency's MBRX Position: Q2 2020 in Review

Patriot Financial Group Insurance Agency sold out of Moleculin Biotech (MBRX) in Q2 2020, closing a stake of 1 share — an estimated $2K sold.

Patriot Financial Group Insurance Agency first reported a position in MBRX in Q4 2018 and held it in 6 quarters. The position peaked at $3K in Q3 2019. 24 funds tracked by Wall St. Rank hold MBRX as of Q2 2020.

  • Patriot Financial Group Insurance Agency reported no remaining Moleculin Biotech position as of Q2 2020 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 1 Moleculin Biotech share in Q2 2020, an estimated $2K.
  • Patriot Financial Group Insurance Agency first reported a position in Moleculin Biotech in Q4 2018 and held it in 6 quarters.
  • Patriot Financial Group Insurance Agency's Moleculin Biotech position peaked at $3K in Q3 2019.
  • 24 funds tracked by Wall St. Rank held Moleculin Biotech as of Q2 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2020, filed 10 Jul 2020.